Issues related to medical research funding. Issues related to theranostics report language in House Report 119-271 and Senate Report 119-55. Issues related to theranostics research within the Congressionally Directed Medical Research Programs (CDMRP).
Budget/Appropriations · 2026 Q1
Issues related to physician payment reform. Issues related to CMS reimbursement for radiopharmaceuticals.
Medicare/Medicaid · 2026 Q1
Issues related to tariffs on nuclear medicines and radiopharmaceuticals.
Tariff (miscellaneous tariff bills) · 2026 Q1
Issues related to the Nuclear Regulatory Commission's preliminary proposed rule titled, "Reporting Nuclear Medicine Injection Extravasations as Medical Events" (10 CFR 35). Issues related to the Nuclear Medicine Clarification Act of 2025 (H.R. 2541).
Energy/Nuclear · 2026 Q1
Issues related to theranostics research within the Congressionally Directed Medical Research Programs (CDMRP).
Defense · 2026 Q1
Issues related to mental health policy, including counseling accreditation and certification.